An Open Label Study to Evaluate the Impact of Duration of Subcutaneous Infusion of a Novel, pH Neutral Formulation of Furosemide (Furoscix®) on Safety and Local Skin Tolerability
Clinical trial NCT04161482 · COMPLETED
Trial details
- NCT number
- NCT04161482
- Sponsor
- scPharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-02
- Primary completion
- 2020-06-24
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.